Structure of the murine CD94 – NKG2A receptor in complex with Qa‐1 b presenting an MHC‐I leader peptide
The FEBS Journal · 2024
DOI: 10.1111/febs.17050 ↗Kurz gefasst
Fachartikel in der Zeitschrift The FEBS Journal, 2024. Verfasst von Bruce J MacLachlan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Infection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Aus…. Hauptthemen laut MEDLINE: HLA-E Antigens, Protein Sorting Signals. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NHMRC, Victorian Cancer Agency Fellowship, National Health and Medical Research Council.
Abstract (Originalsprache)
The heterodimeric natural killer cells antigen CD94 (CD94)–NKG2‐A/NKG2‐B type II integral membrane protein (NKG2A) receptor family expressed on human and mouse natural killer (NK) cells monitors global major histocompatibility complex (MHC) class I cell surface expression levels through binding to MHC class Ia‐derived leader sequence peptides presented by HLA class I histocompatibility antigen, alpha chain E (HLA‐E; in humans) or H‐2 class I histocompatibility antigen, D‐37 (Qa‐1 b ; in mice). Although the molecular basis underpinning human CD94–NKG2A recognition of HLA‐E is known, the equivalent interaction in the murine setting is not. By determining the high‐resolution crystal structure of murine CD94–NKG2A in complex with Qa‐1 b presenting the Qa‐1 determinant modifier peptide (QDM), we resolved the mode of binding. Compared to the human homologue, the murine CD94–NKG2A–Qa‐1 b –QDM displayed alterations in the distribution of interactions across CD94 and NKG2A subunits that coincide with differences in electrostatic complementarity of the ternary complex and the lack of cross‐species reactivity. Nevertheless, we show that Qa‐1b could be modified through W65R + N73I mutations to mimic HLA‐E, facilitating binding with both human and murine CD94–NKG2A. These data underscore human and murine CD94–NKG2A cross‐species heterogeneity and provide a foundation for humanising Qa‐1b in immune system models.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Infection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Australia.
- Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Parkville, Australia.
- Institute of Infection and Immunity, School of Medicine, Cardiff University, UK.
ORCID-Profile: Julian P Vivian
Förderung
- NHMRC
- Victorian Cancer Agency Fellowship
- National Health and Medical Research Council
Zitieren
APA
MacLachlan, B. J., Sullivan, L. C., Brooks, A. G., Rossjohn, J., & Vivian, J. P. (2024). Structure of the murine CD94 – NKG2A receptor in complex with Qa‐1 b presenting an MHC‐I leader peptide. The FEBS Journal. https://doi.org/10.1111/febs.17050
Vancouver
MacLachlan BJ, Sullivan LC, Brooks AG, Rossjohn J, Vivian JP. Structure of the murine CD94 – NKG2A receptor in complex with Qa‐1 b presenting an MHC‐I leader peptide. The FEBS Journal. 2024. doi:10.1111/febs.17050
BibTeX
@article{MacLachlan2024,
author = {MacLachlan, Bruce J and Sullivan, Lucy C and Brooks, Andrew G and Rossjohn, Jamie and Vivian, Julian P},
title = {Structure of the murine CD94 – NKG2A receptor in complex with Qa‐1 b presenting an MHC‐I leader peptide},
journal = {The FEBS Journal},
year = {2024},
doi = {10.1111/febs.17050}
}
EUVIMED